HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Capricor Therapeutics

Contributing Author

Recent Articles by Capricor Therapeutics

Jun-24
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy CAPR GlobeNewswire
Jun-20
Capricor Therapeutics Announces Positive 4-Year Data from HOPE-2 Open-Label Extension Study of Deramiocel in Duchenne Muscular Dystrophy CAPR GlobeNewswire
Jun-17
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program CAPR GlobeNewswire
Jun-11
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program CAPR GlobeNewswire
May-13
Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update CAPR GlobeNewswire
May-13
Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer CAPR GlobeNewswire
May-06
Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13 CAPR GlobeNewswire
May-05
Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy CAPR GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite